---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-275680"
form_type: "8-K"
ticker: "PRLD"
cik: "0001678660"
company_name: "Prelude Therapeutics Inc"
filed_at: "2021-09-17T23:59:59+00:00"
generated_at: "2026-06-29T02:59:10.809474+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# EVP and Chief of Business Operations Christopher Pierce resigns effective Sept 30, 2021

## Summary
- Christopher Pierce resigns as EVP and Chief of Business Operations, effective Sept 30, 2021.
- Resignation is to pursue another employment opportunity.
- No replacement named in the filing.

## SEC filing metadata
- accession: 0001193125-21-275680
- form_type: 8-K
- ticker: PRLD
- cik: 0001678660
- company_name: Prelude Therapeutics Inc
- filed_at: 2021-09-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1678660/000119312521275680/0001193125-21-275680-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1678660/000119312521275680/d198573d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-275680
- JSON: https://secwatch.observer/filing/0001193125-21-275680.json
- Plain text: https://secwatch.observer/filing/0001193125-21-275680.txt

## Key facts
- Executive change
  Christopher Pierce resigned as Executive Vice President and Chief of Business Operations at Prelude Therapeutics Inc.
  - Action: resigned
  - Role: Executive Vice President and Chief of Business Operations
  source text: On September 16, 2021, Prelude Therapeutics Incorporated. (the “Company”) received notice from Christopher Pierce of his intention to resign as Executive Vice President and Chief of Business Operations of the Company effective on September 30, 2021, in order to pursue another employment opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1678660/000119312521275680/0001193125-21-275680-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.